1-158939091-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152501.5(PYHIN1):āc.423A>Cā(p.Lys141Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000522 in 1,581,564 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152501.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PYHIN1 | NM_152501.5 | c.423A>C | p.Lys141Asn | missense_variant | 4/9 | ENST00000368140.6 | NP_689714.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYHIN1 | ENST00000368140.6 | c.423A>C | p.Lys141Asn | missense_variant | 4/9 | 1 | NM_152501.5 | ENSP00000357122.1 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000411 AC: 91AN: 221564Hom.: 0 AF XY: 0.000358 AC XY: 43AN XY: 120134
GnomAD4 exome AF: 0.000539 AC: 771AN: 1429338Hom.: 1 Cov.: 30 AF XY: 0.000512 AC XY: 364AN XY: 710348
GnomAD4 genome AF: 0.000355 AC: 54AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.423A>C (p.K141N) alteration is located in exon 4 (coding exon 3) of the PYHIN1 gene. This alteration results from a A to C substitution at nucleotide position 423, causing the lysine (K) at amino acid position 141 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at